The Department of Health Systems and Services, Medicines and Health Technologies Unit of the Pan American Health Organization organizes the Seminar on Pricing Policies and Other Strategies to Improve Access to MedicinesThe keynote lecture will be given by Professor Panos Kanavos from the London School of Economics and Political Science (LSE).
The Seminar will be held on January 22 at 10:30am Washington, DC time.
Those interested can attend the event via WebEx using the following link: https://paho.webex.com/meet/hta.
Presentations will be made in English and there will be no translation.
Agenda – January 22
10:30 Opening remarks (Isabella Danel – Deputy Director PAHO)
10:45 –12:15
Moderator: James Fitzgerald – Director HSS
Introduction: Analía Porrás (Unit Head – HSS/MT)
Lecture: Panos Kanavos (Deputy Director – LSE Health)
Comments: Amanda Glassman (Director of Global Health Policy – Center for Global Development)
12:15-13:00 Discussion
13:00 Closing
Speakers:
Panos Kanavos (BSc, MSc, PhD) is Professor of International Health Policy in the Department of Social Policy at the London School of Economics (LSE) and Programme Director of the Medical Technology Research Group (MTRG) at LSE Health. He was a Harkness Fellow in Health Care Policy in the Department of Ambulatory Care and Prevention, Harvard Medical School. An economist by training, he currently coordinates the Programme in International Health Policy at LSE and teaches Health Economics, Pharmaceutical Economics and Policy, Health System Finance, and Health System Performance Indicators.
Panos Kanavos leads the activities of MTRG, which is a research unit comprising 11 researchers at LSE Health, with a focus on interdisciplinary and comparative research into medical technology policies. The group pursues the following research streams:
– The economics of medical technologies, in particular medicines and medical devices;
– Prescription, relevance and quality of care;
– Access to medical technologies in developing and transition economies; and
– Disease management and the effectiveness of medical technology policies.
As part of its activities, MTRG manages the Pharmaceutical Policy Issues Programme (PPPI), the Medical Devices Programme, participates in and conducts studies under the auspices of the European Medicines Information Network (EMI-net), participates in the network for the study of rare diseases (BURQOL-RD), and is a member of the European Health Technology Institute for Socio-Economic Research (EHTI). It also coordinates the activities of the Patients' Academy, an initiative between academia, healthcare regulatory agencies and patient groups.
Panos Kanavos has served as an advisor to several international governmental and non-governmental organisations, including the European Commission, the European Parliament, the World Bank, the World Health Organisation, the Organisation for Economic Co-operation and Development, the American Association of Retired Persons and the ministries of health of over 21 transition and developing countries. He has participated in the European Pharmacists Forum as an advisor to the European Commission – Directorate-General for Enterprise and was part of the Commission’s reflection process on the economic aspects of medical devices.
Amanda Glassman Amanda Glassman is the Vice President for Programs, Director of Global Health Policy, and Senior Fellow at the Center for Global Development, leading work on prioritization, resource allocation, and value for money in global health, with a particular interest in vaccination. She has 20 years of experience working on health and social protection policies and programs in Latin America and other developing countries. Prior to her current position, Amanda Glassman was Technical Director for Health at the Inter-American Development Bank (IDB), where she led health economics and financing knowledge products and policy dialogue with member countries, designed the results-based grant program “Salud Mesoamérica 2015,” and served as team leader for conditional cash transfer programs such as Mexico’s Oportunidades and Colombia’s Familias en Acción.
From 2005-2007, Amanda Glassman was Deputy Director of the Global Health Financing Initiative at Brookings, conducting research on aid effectiveness policy and domestic financial issues in the health sector in low-income countries. Prior to joining the Brookings Institution, Amanda Glassman designed, supervised, and evaluated health and social protection loans at the IDB and served as a Population Reference Bureau Fellow at the U.S. Agency for International Development. She holds a master’s degree from the Harvard School of Public Health and is a graduate of Brown University.